Abstract
Familial hypoalphalipoproteinemias (HA) are a heterogenous group of disorders characterized by various degrees of HDL deficiency. Differential diagnosis involves clinical and biochemical evaluation after intervention designed to correct known secondary causes of low HDL. Two specific HAs are discussed in this report: 1. primary isolated HA (PIHA) is a poorly characterized entity with an apparent autosomal dominant transmission and distinct abnormalities in the structure and function of HDL. 2. Lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes are caused by a number of different genetic defects that lead to at least two distinct clinical presentations i.e. familial LCAT deficiency and fish eye disease. PIHA is an example of a genetic disorder whose diagnosis would greatly be improved by the availability of molecular diagnostic tests. Conversely, the effect of the genetic heterogeneity of LCAT deficiency syndromes on diagnosis is best overcome by utilizing existing biochemical measurement of LCAT activity and the plasma cholesterol esterification rate.
Similar content being viewed by others
References
Eisenberg S: High density lipoprotein metabolism. J Lipid Res 25: 1017–1058, 1984
Fruchart J-C, Theret N, Barbaras R, Puchois P, Ailhaud G: Apo A-containing lipoprotein particles. Physiological role, quantification and clinical significance. In: A Lars (ed.) Disorders of HDL. Smith-Gordon Publishers, London, 1990, pp 71–75
Nichols AV, Blanche PJ, Gong EL: Gradient gel electrophoresis of human plasma high density lipoproteins. In: L Lewis, J Opplt (eds.) CRC Handbook of electrophoresis, Vol III. Boca Raton, FL: CRC Press, 1983, pp 29–47
Cheung MG, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography: Particles containing A-1 and A-II and particles containing A-I but no A-II. J Biol Chem 259, 12201–12209, 1984
Carlson LA: Disorders of HDL. (ed.) Smith-Gordon Publishers, London, 1990
Castelli W, Doyle JT, Gordon T et al.: HDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation 55: 767–772, 1977
Gordon T, Castelli WP, Hjortland MC et al.: High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 62: 707–714, 1977
Goldbourt U, Medalie JH: High density lipoprotein cholesterol and incidence of coronary heart disease: The Israeli ischaemic heart disease study. Am J Epidemiol 109: 296–308, 1979
Castelli WP, Garrison RJ, Wilson PWF et al.: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 256: 2835–2838, 1986
Keyes A, Karvonen JM, Punsar S et al.: HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol 13: 428–435, 1984
Assman G. Schulte H: PROCAM Trial, Pansientia Verlag, Zurich, 1986
Frick MH, Elo O, Haapa K et al.: Helsinki heart study: Primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317: 1237–1245, 1987
Vergani C, Bertalle A: Familial hypoalphalipoproteinemia. Clin Chem Acta 114: 45–52, 1983
Norum RA, Lakier JB, Goldstein S et al.: Familial deficiency of apolipoprotein A-I and C-III and precocious coronary artery disease. N Engl J Med 306: 1519, 1982
Schaefer EJ, Ordovas JM, Law SW et al.: Familial apolipoprotein A-I and CIII deficiency, variant II. J Lipid Res 26: 1089–1101, 1985
Gjone E, Norum KR, Glomset JA: Familial LCAT deficiency. In: JB Stanbury, JB Wyngaarden, DS Fredrickson (eds.) The metabolic basis of inherited disease. McGraw-Hill, New York, 1978, pp 589–603
Frohlich J, McLeod R: Lecithin: Cholesterol acyltransferase deficiency syndromes. Adv Exp Biol Med 201: 181–194, 1986
Carlson LA: Fish-eye disease: A new familial condition with massive corneal opacities and dyslipoproteinemia. Eur J Clin Invest 12: 41–53, 1982
Frohlich J, Hoag G, McLeod R et al.: Hypoalphalipoproteinemia resembling fish eye disease. Acta Med Scand 221: 291–298, 1987
Funke H, von Eckardstein A, Pritchard PH, Karas M, Albers JJ, Assmann G: A frameshift mutation in the apolipoprotein A-I gene causes HDL deficiency, partial LCAT deficiency, and corneal opacities: A disorder which is biochemically distinct from fish eye disease. J Clin Invest 87: 371–376, 1991
Norum RA, Alaupovic P: J Lipid Res 1992 (in press)
Herbert PN, Assmann G, Gotto Jr AM, Fredrickson DS: Familial lipoprotein deficiency: Abetalipoproteinemia, hypobetalipoproteinemia, and Tangier disease. In: JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, MS Brown (eds.) The metabolic basis of inherited disease. New York, McGraw-Hill, 1983, pp 589–621
Frohlich J, Pritchard PH, Sparks DL, Westerlund J: Primary isolated hypo-α-lipoproteinemia: A distinct familial lipoprotein abnormality: In: L Carlson (ed.) Disorders of High Density Lipoprotein. Smith Gordon Ltd, Lon. 1990, pp 177–184
Sparks DL, Frohlich J, Lacko AG, Pritchard PH: The relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients. Atherosclerosis 77: 183–191, 1989
Sparks DL, Pritchard PH: The effect of the neutral lipid core of recombinant high density lipoproteins on lecithin: cholesterol acyltransferease activity. Biochem Cell Biol 67: 358–364, 1989
Sparks DL, Pritchard PH: The effect of lipid and apo protein content of high density lipoprotein on the transfer of cholesteryl esters from cholesteryl ester transfer protein. J Lipid Res 30: 1491–1498, 1989
Sparks DL, Pritchard PH: Abnormal HDL composition results in defective transport of cholesteryl ester. Circulation 80 (Suppl 2): 454, 1989
Sparks DL, Frohlich J, Pritchard PH: Hyperlipidemia and cholesterol transport. Am Heart J 122: 601–607, 1991
Ordovas JM, Schaefer EJ, Salem D et al.: Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Eng J Med 314: 617–7, 1986
Kastelein JJP, Hayden MR, Langlois S: Familial hypoalphalipoproteinemia (Abstr.) 8th Intl Symposium on Atherosclerosis. Rome, October 9–13, 443, 1988
Taramelli R, Pontoglio M, Candiani G et al.: Lecithin cholesterolacyl transferase deficiency: Molecular analysis of a mutated allele. Human Gen 85: 195–199, 1991
Maeda E, Naka Y, Matozaki T, Sakuma M, Akanuma Y, Yoshino G, Kasuga M: Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene. Biochem Biophys Res Commun 178: 460–466, 1991
Gotoda T, Yamada N, Murase T et al.: Differential phenotypic expression by three mutant alleles in familial lecithin: cholesterol acyl transferase deficiency. Lancet 338: 778–781, 1991
Funcke H, von Eckardstein A, Pritchard PH, Albers JJ, Kastelein JJP, Assmann G: The molecular defect causing Fish Eye Disease. Proc Natl Acad Sci 88: 4855–4859, 1991
Magil A, Chase W, Frohlich J: Unusual renal biopsy in a patient with familial lecithin: cholesterol acyltransferase deficiency. Human Path 13: 183–185, 1982
Godin DV, Gray G, Frohlich J: Erythrocyte membrane alterations in lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest 38 (Suppl. 150): 162–167, 1978
Carlson LA, Holmquist L: Paradoxical esterification of plasma cholesterol in fish eye disease. Acta Med Scand 217: 491–498, 1985
Forte T, Carlson LA:Electron microscopic structure of serum lipoproteins from patients with fish eye disease. Arterosclerosis 4: 130–136, 1984
Von Eckardstein A, Funke H, Henke A, Altand K, Benninghoven A, Assmann G: Apolipoprotein A-I variants. J Clin Invest 84: 1722–1730, 1989
Frohlich J, McLeod R, Pritchard PH: Plasma lipoprotein abnormalities in heterozygotes for familial lecithin: cholesterol acyltransferase deficiency. Metabolism 37: 3–8, 1988
Brunzell JD: Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: CR Scriver, AL Beaudet, WS Sly, D Valle (eds.) The Inherited Basis of Metabolic Disease. 1989, pp 1165–1180
Breslow JL: Familial Disorders of High Density. In: CR Scriver, AL Beaudet, WS Sly, D Valle (eds.) The Inherited Basis of Metabolic Disease. 1989, pp 1251–1266
Moorjani S, personal communication
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frohlich, J., Pritchard, P.H. Analysis of familial hypoalphalipoproteinemia syndromes. Mol Cell Biochem 113, 141–149 (1992). https://doi.org/10.1007/BF00231534
Issue Date:
DOI: https://doi.org/10.1007/BF00231534